CCL2 and neoplasm: Activation of Cysteine-rich 61 protein (CCN1) also inhibited the oncolytic virus anti-tumor efficacy in glioblastoma through activation and infiltration of inflammatory TAMs and NK cells expressing IL-1β, IFNγ, CXCL10, and MCP-1/3 [43,44].